Related Experiment Video
Updated: Aug 15, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
1Department of Ophthalmology, Ambroise Paré Hospital, University of Paris-Ouest, Boulogne, France.
Abstract:
An increasing number of studies, both experimental and epidemiologic, have provided evidence that filtering glaucoma surgery may be less effective than initially described. Of a number of risk factors for failure, duration and number of antiglaucoma drugs prior to surgery seem to play a critical role and highly accumulated antiglaucoma topical treatments significantly reduce success rates. Histopathological studies have confirmed that topically applied drugs may exert toxic effects to the corneoconjunctival surface, and induce chronic infraclinical inflammation, as shown by the presence of immune and inflammatory infiltrates in multitreated eyes. The origin of topical inflammation has not yet been clearly determined, but a common component of ophthalmic drugs, the benzalkonium chloride used as preservative in almost all antiglaucoma preparations, has shown strong evidence of toxicity. A number of questions remain to be investigated, but suppression of preservatives from chronically applied drugs should be a critical issue in the near future.
Insights
Glaucoma surgery success may decrease with prolonged use of antiglaucoma drugs. Preservatives like benzalkonium chloride in these eye drops may cause inflammation and reduce surgical outcomes.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Drug Toxicology
Background:
- Filtering glaucoma surgery effectiveness is increasingly questioned.
- Preoperative use of antiglaucoma medications is a significant risk factor for surgical failure.
- Chronic topical treatments can cause corneoconjunctival toxicity and inflammation.
Purpose of the Study:
- To investigate the impact of antiglaucoma drug usage on filtering glaucoma surgery outcomes.
- To identify the role of topical drug toxicity and inflammation in surgical failure.
- To highlight the potential contribution of preservatives to adverse effects.
Main Methods:
- Review of experimental and epidemiological studies on glaucoma surgery.
- Histopathological examination of corneoconjunctival tissues from patients using antiglaucoma medications.
- Analysis of risk factors associated with reduced surgical success rates.
Main Results:
- Extended duration and higher number of antiglaucoma drugs significantly decrease success rates.
- Topical antiglaucoma treatments induce chronic inflammation and toxic effects on the eye surface.
- Benzalkonium chloride, a common preservative, shows strong evidence of toxicity.
Conclusions:
- Antiglaucoma drug toxicity and inflammation are critical factors affecting filtering glaucoma surgery success.
- Reducing or eliminating preservatives like benzalkonium chloride in eye drops is crucial for future treatments.
- Further investigation into preservative-free antiglaucoma formulations is warranted.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems

